Join the DDA or

Alliance Calcium Syrup and DDAVP Desmopressin supply notifications

Out of stock and discontinuation

May 28th 2021

Tagged: supply shortages

By Ailsa Colquhoun

DHSC has published tier two medicine supply notifications for Alliance Calcium Syrup (calcium gluconate 544mg/5ml / calcium lactate 276mg/5ml oral solution) and DDAVP Desmopressin 100mcg per 1ml intranasal solution

Medicine

Out of stock until

Alternatives

Alliance Calcium Syrup (calcium gluconate 544mg/5ml / calcium lactate 276mg/5ml oral solution)

Mid-September 2021

  • Any remaining supplies of Alliance Calcium Syrup® should be reserved for neonates and patients in whom alternative options are not appropriate.
  • All other patients should be switched to an alternative calcium formulation:

DDAVP (Desmopressin)0.01% w/v (100mcg/ 1ml) intranasal solution
(Updated MSN)

Discontinued

  • Supplies of desmopressin 100 micrograms/ml nasal spray (10 micrograms per actuation) remain available from Aspire Pharma Ltd for patients on doses ≥ 10 microgram.
  • Desmopressin tablets and oral lyophilisates remain available.
  • Unlicensed imports have also been sourced.

 There have also been changes to the resupply dates of the medicines listed below.

Original MSN reference

Date of original MSN/SDA

Supply issue

Resupply date originally communicated

Updated resupply date as of w/c

24 May 2021

MSN/2021/021

09/04/2021

Diamorphine 5mg and 10mg injections

w/c 19 March 2021

5mg to be available in the first week of June

10mg to be OOS from w/c 31 May until late June

MSN/2021/025

11/05/2021

Flixotide (Fluticasone) 100 microgram accuhaler

w/c 31 May 2021

w/c 28  June 2021

MSN/2020/057

21/10/2020

Fluoxetine 30mg capsules

Mid-December 2020

Delayed, TBC

MSN/2020/011

12/03/2020

Fluoxetine 10mg tablets

Late 2020

March 2022